7 results
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Drugs #Antiarrhythmic ... #Pharmacology # ... Cardiology #Table ... #Effects
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics ... Indications, Side Effects ... #ClassI #Na #cardiology ... #pharmacology # ... table #comparison
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - ... Pharmacology Comparison ... limited by side effects ... #Blockers #Pharmacology ... #Receptors #cardiology
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
Class III Antiarrhythmics ... Indications and Side Effects ... a-flutter (when other drugs ... #pharmacology # ... cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
increased bleed risk Beta-Blockers ... of beta-blockers ... arrhythmias Class I Antiarrhythmic ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Antiarrhythmics ... channel blocking effects ... duration CLASS 2 - Beta ... block alpha & beta ... Vaughan #Williams #Pharmacology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics ... Pharmacology Summary ... duration CLASS 2 - Beta ... block alpha & beta ... #Pharmacology #